A Phase 1 Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors
NCT05983133 · ACTIVE NOT RECRUITING · Phase 1
We track 7 ClinicalTrials.gov studies led by Seagen A Wholly Owned Subsidiary Of Pfizer. The portfolio skews toward Phase 1 (3 trials).
7 clinical trials sponsored by Seagen A Wholly Owned Subsidiary Of Pfizer.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 3 | 43% |
| Phase 3 | 2 | 29% |
| Phase 2 | 2 | 29% |
Seagen A Wholly Owned Subsidiary Of Pfizer currently sponsors 7 clinical trials tracked on ReadTheTrial. These span Phase 1, Phase 3, Phase 2.
Seagen A Wholly Owned Subsidiary Of Pfizer conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Seagen A Wholly Owned Subsidiary Of Pfizer currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.